Cabot (NYSE:CBT) Stock, Quote.Headers.trade-ideas

Cabot

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into two segments based on the product type. The reinforcement materials segment, which generates more revenue than any other segment, sells rubber-grade carbon black products used in hoses and belts in automobiles. The performance chemicals segment sells ink-jet colorants and metal oxides used in the automotive and construction industries.

Earnings

Earnings Beats

News

Markets

Analyst Ratings

Trading Ideas

AXTA

CF Industries Holdings, Inc. (NYSE: CF) is poised to gain from higher nitrogen fertilizer demand in major markets and lower natural gas costs amid headwinds from softer nitrogen prices.

The company&#39;s shares have declined 4.1% over a year compared with a 25.3% decline of its industry.

Here&#39;s Why You Should Hold Onto CF Industries Stock for Now

Celanese Corporation (NYSE: CE) is expected to benefit from its investments in high-return organic projects, cost and productivity actions and synergies of acquisitions. However, it faces headwinds from weak demand in certain end markets and pricing pressures.

Here&#39;s Why You Should Hold Onto Celanese Stock for Now

Options

Investors in Cabot Corporation (NYSE: CBT) need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 19, 2024 $80 Call had some of the highest implied volatility of all equity options today.

Do Options Traders Know Something About Cabot Stock We Don&#39;t?

Cabot Corp

XTRA Bitcoin Inc

Cannabotech Ltd

CITIZENS BNCRP INVT INC A by Citizens Bancorp Investment, Inc.

Citizens Bancorp Investment Inc

CATHEDRA BITCOIN INC by Cathedra Bitcoin Inc

Cathedra Bitcoin Inc

CF Industries Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cf#NYSE">CF</a>) is poised to gain from higher nitrogen fertilizer demand in major markets and lower natural gas costs amid headwinds from softer nitrogen prices.
The company&#39;s shares have declined 4.1% over a year compared with a 25.3% decline of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/b7/70849.jpg?v=912933296" />
Image Source: Zacks Investment Research
Let&#39;s find out why this Zacks Rank #3 (Hold) stock is worth retaining at the moment.
<h3>CF Gains on Healthy Nitrogen Demand, Lower Gas Costs</h3>
CF Industries is benefiting from rising global demand for nitrogen fertilizers, driven by significant agricultural demand. Industrial demand for nitrogen has also recovered from the pandemic-related disruptions. The company sees global demand to remain strong in the near future due to recovering industrial demand and farmer economics.
High levels of corn planted acres, low nitrogen channel inventories and favorable farm economics are expected to drive demand for nitrogen in North America. Demand for urea is also expected to remain strong in Brazil and India. Demand in India is expected to be driven by an uptick in domestic production on the back of higher operating rates and favorable weather conditions.
CF also stands to benefit from lower natural gas prices. It witnessed a significant decline in natural gas costs in the first quarter of 2024. The average cost of natural gas fell to $3.19 per MMBtu in the quarter from $6.62 per MMBtu in the year-ago quarter. Lower natural gas costs led to a decline in the company&#39;s cost of sales. The benefits of reduced gas costs are expected to continue in the second quarter of 2024.
Moreover, CF remains committed to boosting shareholders&#39; value by leveraging strong cash flows. In the first quarter of 2024, the company repurchased 4.3 million shares for $347 million. The current $3 billion share repurchase program had around $2.2 billion remaining at the end of the first quarter. Earlier this year, the company also announced a 25% increase in quarterly dividend to 50 cents per share.
<h3>Weaker Nitrogen Prices Weigh on Margins</h3>
CF is exposed to headwinds from softer nitrogen prices. Global nitrogen prices have declined since the beginning of 2023. Higher global supply availability driven by higher global operating rates due to lower global energy costs has resulted in a decline in prices. Lower average selling prices weighed on CF&#39;s top line in the first quarter.
Selling prices fell in the quarter as decreased global energy costs reduced the global market clearance price required to meet global demand. The weak pricing environment is expected to continue over the near term. Lower pricing is likely to continue weighing on the company&#39;s sales and margins.
<h3>Stocks to Consider</h3>
Better-ranked stocks in the basic materials space include Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>), Axalta Coating Systems Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axta#NYSE">AXTA</a>) and Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>).
Carpenter Technology currently carries a Zacks Rank #1 (Strong Buy). CRS beat the Zacks Consensus Estimate in three of the last four quarters while matching it once, with the average earnings surprise being 15.1%. The company&#39;s shares have soared roughly 90% in the past year.
Axalta Coating Systems, carrying a Zacks Rank #2 (Buy), has a projected earnings growth rate of 26.8% for the current year. In the past 60 days, the consensus estimate for AXTA&#39;s current-year earnings has been revised upward by 5.9%. The company&#39;s shares have gained roughly 3% in the past year.
Cabot currently carries a Zacks Rank #2. CBT has a projected earnings growth rate of 29% for the current fiscal year. The company&#39;s shares have rallied around 33% in the past year.
<a href="https://www.zacks.com/stock/news/2299045/here-s-why-you-should-hold-onto-cf-industries-cf-stock-for-now?cid=CS-BENZ-FT-analyst_blog|rank_focused-2299045">To read this article on Zacks.com click here.</a>

Here's Why You Should Hold Onto CF Industries Stock for Now

Celanese Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ce#NYSE">CE</a>) is expected to benefit from its investments in high-return organic projects, cost and productivity actions and synergies of acquisitions. However, it faces headwinds from weak demand in certain end markets and pricing pressures.
The company&#39;s shares have gained 14.6% in a year against a 13.3% decline of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/18/70695.jpg?v=594454220" />
Image Source: Zacks Investment Research
Let&#39;s find out why this Zacks Rank #3 (Hold) stock is worth retaining at the moment.
<h3>Acquisitions &amp; Productivity Aid Celanese</h3>
Celanese&#39;s strategic acquisitions have provided it with opportunities for additional growth, investment and synergies. The acquisition of the majority of DuPont&#39;s Mobility &amp; Materials (&quot;M&amp;M&quot;) business has allowed Celanese to enhance its growth in high-value applications. Celanese expects incremental M&amp;M synergies of at least $150 million during 2024.
The acquisitions of SO.F.TER., Nilit and Omni Plastics are also expected to contribute to earnings expansion in the company&#39;s Engineered Materials segment. The Elotex acquisition also strengthened the company&#39;s position in the vinyl acetate ethylene emulsions space. Moreover, the purchase of Exxon Mobil&#39;s Santoprene business broadened the company&#39;s portfolio of engineered solutions and enabled it to offer a wider range of functionalized solutions to targeted growth areas, including future mobility, medical and sustainability.
Celanese also remains focused on executing its productivity programs including the implementation of several cost-reduction capital projects. Productivity actions are expected to support its margins in 2024.
The company is proactively implementing strategic initiatives recognizing the volatility and unpredictability of the current market landscape and competitive environment. These actions involve strengthening its commercial teams, aligning production and inventory levels with prevailing demand, implementing cost-saving measures and optimizing cash flow. These endeavors are expected to result in strong cash generation and a continuation of earnings growth.
Celanese has also completed the startup of a new 1.3-million-ton Clear Lake acetic acid expansion unit and a new vinyl acetate ethylene unit in Nanjing. It expects the Clear Lake expansion to contribute to higher earnings performance in the second quarter and into the second half of 2024.
Moreover, Celanese continues to generate strong cash flows and is focused on boosting shareholders&#39; value and deleveraging its balance sheet. It generated a record operating cash flow of $1.9 billion and a free cash flow of $1.3 billion in 2023. CE returned $305 million to shareholders through dividend payouts during 2023. Moreover, the company reduced its net debt by $1.3 billion in 2023. It expects to continue reducing its net debt in 2024. The company, in its first-quarter call, said that it expects to repay over $2 billion in total debt maturities over the next four quarters.
<h3>Soft Demand &amp; Pricing a Concern</h3>
CE is exposed to headwinds from demand softness in some of its end markets. It witnessed weak demand in several end markets and destocking in 2023. Soft demand led to inventory reduction and deferral of orders by the company&#39;s customers. Demand remains sluggish in industrial and consumer goods end markets. The company continues to see subdued demand in Europe. Demand conditions are yet to return to normal levels. Weaker demand recovery globally is likely to weigh on the company&#39;s volumes in the near term.
Celanese is also being challenged by significant competition. Competitive pressure is hurting its prices. CE saw lower pricing on a year-over-year basis across its segments in the first quarter. The company expects the pricing pressure to continue due to the challenging competitive dynamics in the second quarter of 2024.
<h3>Stocks to Consider</h3>
Better-ranked stocks in the basic materials space include Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>), Axalta Coating Systems Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axta#NYSE">AXTA</a>) and Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>).
CRS beat the Zacks Consensus Estimate in three of the last four quarters while matching it once, with the average earnings surprise being 15.1%. The company&#39;s shares have soared roughly 93% in the past year. Carpenter Technology currently carries a Zacks Rank #1 (Strong Buy).
Axalta Coating Systems, carrying a Zacks Rank #2 (Buy), has a projected earnings growth rate of 26.8% for the current year. In the past 60 days, the consensus estimate for AXTA&#39;s current-year earnings has been revised upward by 5.9%. The company&#39;s shares have gained roughly 6% in the past year.
Cabot currently carries a Zacks Rank #2. CBT has a projected earnings growth rate of 26% for the current fiscal year. The company&#39;s shares have rallied around 33% in the past year.
<a href="https://www.zacks.com/stock/news/2298431/here-s-why-you-should-hold-onto-celanese-ce-stock-for-now?cid=CS-BENZ-FT-analyst_blog|rank_focused-2298431">To read this article on Zacks.com click here.</a>

Here's Why You Should Hold Onto Celanese Stock for Now

Investors in Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>) need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 19, 2024 $80 Call had some of the highest implied volatility of all equity options today.
<h3>What is Implied Volatility?</h3>
Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
<h3>What do the Analysts Think?</h3>
Clearly, options traders are pricing in a big move for Cabot shares, but what is the fundamental picture for the company? Currently, Cabot is a Zacks Rank #2 (Buy) in the Chemical - Diversified industry that ranks in the Bottom 27% of our Zacks Industry Rank. Over the last 60 days, three analysts have increased their earnings estimates for the current quarter, while one has dropped the estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter from $1.72 per share to $1.74 in that period.
Given the way analysts feel about Cabot right now, this huge implied volatility could mean there&#39;s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
<a href="https://www.zacks.com/stock/news/2296504/do-options-traders-know-something-about-cabot-cbt-stock-we-don-t?cid=CS-BENZ-FT-tale_of_the_tape|options-2296504">To read this article on Zacks.com click here.</a>

Do Options Traders Know Something About Cabot Stock We Don't?

The chemical industry is poised to benefit from an uptick in demand in certain key markets, including consumer durables and building &amp; construction, as the unprecedented customer inventory de-stocking that started in late 2022 and plagued the industry through the first quarter of 2024 is largely complete. 
In addition to the expected demand rebound, strategic measures, including operating cost reduction and price hike actions along with declining raw material costs, bode well for the industry. Stocks like DuPont de Nemours, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dd#NYSE">DD</a>), Axalta Coating Systems Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axta#NYSE">AXTA</a>), Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>) and Kronos Worldwide, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kro#NYSE">KRO</a>) are good choices for investment as they are expected to benefit from the demand upturn. 
The chemical space bore the brunt of the demand slowdown in certain major markets in 2023, which continued through first-quarter 2024. The downturn in the building &amp; construction market and the de-stocking in consumer electronics played spoilsport, leading to demand destruction in these key markets. In North America, uncertainties surrounding the U.S. housing market weighed on building &amp; construction. Notably, the housing market bore the brunt of interest rate hikes last year. The demand slowdown in industrial and consumer durables hurt the volumes of chemical companies. 
Lower consumer spending due to inflationary pressures in Europe and a slow recovery in China also impacted demand. Moreover, a slower recovery in economic activities in China following the lifting of the restrictions related to the resurgence in COVID-19 infections hurt chemical demand in that country. The slowdown in Europe, resulting from the war in Ukraine and weaker consumer spending due to high levels of inflation, led to softer demand in that region. The energy and feedstock inflation resulted in reduced industrial production and consumer spending in Europe. 
Nevertheless, customer inventory de-stocking has largely ended, leading to low inventory levels. This should result in an uptick in chemical demand and volumes, with a meaningful improvement expected in the second half of 2024. The de-stocking was primarily driven by high inflation and the lingering impacts of the pandemic that affected customer spending. 
Demand for chemicals in the automotive market has picked up, aided by an uptick in automotive production on an improved supply of semiconductors. The resolution to the six-week United Auto Workers strike also led to a rebound in chemical demand in automotive. Moreover, chemical companies are seeing a recovery in demand across the construction and electronics markets. Demand in healthcare and packaging markets also remains steady. 
Moderating raw material and energy costs driven by the easing of supply-chain disruptions is also expected to act as a tailwind. Meanwhile, industrial production is picking up pace in China on a recovery in external demand, underscoring improving conditions in the world&#39;s second-largest economy. However, the recovery in domestic demand in China remains slow due to the protracted crisis in real estate. Easing inflation on a decline in energy prices is also likely to support demand recovery in Europe.&nbsp;
<h3>4 Chemical Stocks Worth a Bet</h3>
A rebound in end-market demand, moderating raw material and energy costs, and the absence of customer inventory destocking augur well for the chemical industry. 
We highlight the following four stocks with a solid Zacks Rank that are good options for investment right now. Our research shows that stocks with a Zacks Rank #1 (Strong Buy) or 2 (Buy) offer good investment opportunities. 
DuPont: Delaware-based DuPont is benefiting from innovation-driven investment focused on several high-growth areas. It remains focused on driving growth through innovation and new product development. The acquisition of Spectrum Plastics Group has also strengthened DuPont&#39;s position in stable and fast-growing healthcare end markets. DuPont is also benefiting from cost synergy savings and productivity improvement actions. Its planned separation into three independent, publicly traded companies is also expected to drive significant growth opportunities. 
DuPont, sporting a Zacks Rank #1, has expected earnings growth of 4.3% for 2024. The Zacks Consensus Estimate for DD&#39;s earnings for 2024 has been revised upward by 4.3% over the last 60 days. It beat the Zacks Consensus Estimate for earnings in each of the last four quarters at an average of roughly 9%. 
Axalta Coating Systems: Pennsylvania-based Axalta is benefiting from the strength in refinish and light vehicle businesses, which is offsetting the weakness in industrial markets. The acquisition of CoverFlexx Group will enhance Axalta&#39;s refinish business by incorporating CoverFlexx&#39;s extensive range of automotive refinish and aftermarket coatings, including primers, basecoats, clearcoats and various detailing products. Axalta has also strategically expanded its portfolio by acquiring Andre Koch AG, a well-established Refinish distribution partner headquartered in Switzerland. Moreover, AXTA has raised its full-year 2024 earnings and free cash flow outlook based on strong first-quarter results and strategic actions to drive earnings. 
Axalta, carrying a Zacks Rank #1, has expected earnings growth of 26.8% for 2024. The Zacks Consensus Estimate for AXTA&#39;s 2024 earnings has been revised upward by 5.9% over the last 60 days. 
Cabot: Massachusetts-based Cabot is seeing strong results in its Reinforcement Materials segment driven by higher volumes in Asia and Europe, pricing and mix improvements, and the strength in the replacement tire market. Demand in the Performance Chemicals unit has also improved as de-stocking has ended. CBT&#39;s strong cash generation also facilitates a balanced capital allocation approach that emphasizes strategic investments, long-term earnings growth and shareholder returns while preserving a solid investment-grade balance sheet. 
Cabot, a Zacks Rank #2 stock, has expected earnings growth of 26% for fiscal 2024. The Zacks Consensus Estimate for CBT&#39;s earnings for fiscal 2024 has been revised upward by 3% over the last 60 days. 
Kronos Worldwide: Texas-based Kronos is expected to gain from higher demand for titanium dioxide (TiO2). Stronger demand for TiO2 in primary markets of Europe and North America is likely to drive its sales volumes. KRO is also expected to benefit from easing pricing pressure. Reduced energy costs, along with cost-reduction initiatives are expected to support margins. 
Kronos Worldwide, carrying a Zacks Rank #2, has expected earnings growth of 297.7% for 2024. The Zacks Consensus Estimate for KRO&#39;s earnings for 2024 has been revised upward by 157.6% over the last 60 days.
<a href="https://www.zacks.com/stock/news/2288317/4-top-chemical-stocks-to-buy-as-destocking-has-run-its-course?cid=CS-BENZ-FT-analyst_blog|investment_ideas-2288317">To read this article on Zacks.com click here.</a>

Small Cap

4 Top Chemical Stocks to Buy As Destocking Has Run Its Course

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) in the last three months.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Cabot and provided 12-month price targets. The average target is $102.75, accompanied by a high estimate of $109.00 and a low estimate of $95.00. Observing a 5.57% increase, the current average has risen from the previous average price target of $97.33. 
<img src="https://www.benzinga.com/files/images/story/2024/1715101259_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Cabot among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$103.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Buy</td>
<td>$109.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$95.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Buy</td>
<td>$104.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Cabot. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Cabot compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Cabot's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Cabot's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CBT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Cabot analyst ratings.</a>
<h2>Unveiling the Story Behind Cabot</h2>
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into two segments based on the product type. The reinforcement materials segment, which generates more revenue than any other segment, sells rubber-grade carbon black products used in hoses and belts in automobiles. The performance chemicals segment sells ink-jet colorants and metal oxides used in the automotive and construction industries.
<h3>Unraveling the Financial Story of Cabot</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Cabot's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2023, the company experienced a revenue decline of approximately -0.73%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 5.11%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Cabot's ROE stands out, surpassing industry averages. With an impressive ROE of 3.78%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.34%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.99.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 4 Analyst Projections For Cabot

UBS analyst Joshua Spector maintains Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) with a Neutral and raises the price target from $100 to $103.

Price Target

UBS Maintains Neutral on Cabot, Raises Price Target to $103

Mizuho analyst John Roberts maintains Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) with a Buy and raises the price target from $104 to $109.

Mizuho Maintains Buy on Cabot, Raises Price Target to $109

Guidance

Cabot Sees FY24 Adj. EPS $6.65-$6.85 Vs $7.59 Estimate

Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) reported quarterly earnings of $1.78 per share which beat the analyst consensus estimate of $1.66 by 7.23 percent. The company reported quarterly sales of $1.02 billion which missed the analyst consensus estimate of $1.05 billion by 2.49 percent. This is a 1.36 percent decrease over sales of $1.03 billion the same period last year.

Earnings Misses

Cabot Q2 2024 Adj EPS $1.78 Beats $1.66 Estimate, Sales $1.02B Miss $1.05B Estimate

Dividends

Cabot Board Raises Dividend From $0.40 To $0.43

Deutsche Bank analyst David Begleiter downgrades Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) from Buy to Hold and raises the price target from $88 to $95.

Downgrades

Deutsche Bank Downgrades Cabot to Hold, Raises Price Target to $95

Grant will support development of innovative, scalable manufacturing processes for producing carbon catalyst supports for fuel cells

Contracts

Cabot Corporation And Partners Selected For $5M In U.S. DoE Grant To Support Fuel Cell Deployment

Mizuho analyst John Roberts initiates coverage on Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) with a Buy rating and announces Price Target of $104.

Initiation

Mizuho Initiates Coverage On Cabot with Buy Rating, Announces Price Target of $104

WIIM

Cabot Corp shares are trading higher after the company reported better-than-expected Q1 results.

Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) reported its Q1 earnings results on Monday, February 5, 2024 at 04:30 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Cabot beat estimated earnings by 4.7%, reporting an EPS of $1.56 versus an estimate of $1.49.
Revenue was down $7.00 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.17 which was followed by a 8.31% increase in the share price the next day.
Here's a look at Cabot's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.48</td>
<td>1.56</td>
<td>1.31</td>
<td>0.97</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.65</td>
<td>1.42</td>
<td>1.33</td>
<td>0.98</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>991.48M</td>
<td>1.15B</td>
<td>1.11B</td>
<td>955.24M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>965.00M</td>
<td>968.00M</td>
<td>1.03B</td>
<td>965.00M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Cabot management provided guidance for FY 2024, expecting earnings between $6.3 and $6.8 per share.
To track all earnings releases for Cabot <a href="https://www.benzinga.com/quote/CBT/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cabot: Q1 Earnings Insights

Cabot's Outlook For 2024 Adjusted EPS Remains In Range Of $6.30-$6.80 (Est. $6.59)

Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) reported quarterly Adj earnings of $1.56 per share which beat the analyst consensus estimate of $1.49 by 4.7 percent. This is a 59.18 percent increase over earnings of $0.98 per share from the same period last year. The company reported quarterly sales of $958.00 million which beat the analyst consensus estimate of $952.85 million by 0.54 percent. This is a 0.73 percent decrease over sales of $965.00 million the same period last year.

Cabot Q1 Adj EPS $1.56 Beats $1.49 Estimate, Sales $958.00M Beat $952.85M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; NAPCO Security Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSSC#NASDAQ">NSSC</a>) is estimated to report quarterly earnings at $0.26 per share on revenue of $43.92 million.
&bull; Affiliated Managers Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMG#NYSE">AMG</a>) is projected to report quarterly earnings at $5.98 per share on revenue of $524.15 million.
&bull; Sphere Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) is expected to report quarterly loss at $0.85 per share on revenue of $300.23 million.
&bull; Bowlero (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOWL#NYSE">BOWL</a>) is estimated to report quarterly earnings at $0.12 per share on revenue of $300.52 million.
&bull; ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) is estimated to report quarterly earnings at $1.21 per share on revenue of $2.00 billion.
&bull; Tyson Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) is likely to report quarterly earnings at $0.40 per share on revenue of $13.36 billion.
&bull; McDonald&#39;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) is likely to report quarterly earnings at $2.82 per share on revenue of $6.45 billion.
&bull; Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) is expected to report quarterly earnings at $0.55 per share on revenue of $4.20 billion.
&bull; IDEXX Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDXX#NASDAQ">IDXX</a>) is expected to report quarterly earnings at $2.11 per share on revenue of $889.85 million.
&bull; Caterpillar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) is projected to report quarterly earnings at $4.75 per share on revenue of $17.11 billion.
&bull; Graham (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHM#NYSE">GHM</a>) is projected to report quarterly loss at $0.03 per share on revenue of $38.94 million.
&bull; CNA Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNA#NYSE">CNA</a>) is likely to report quarterly earnings at $1.10 per share on revenue of $2.95 billion.
&bull; Mitsubishi UFJ Finl Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUFG#NYSE">MUFG</a>) is projected to report earnings for its third quarter.
&bull; Timken (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKR#NYSE">TKR</a>) is estimated to report quarterly earnings at $1.22 per share on revenue of $1.06 billion.
&bull; Loews (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/L#NYSE">L</a>) is likely to report earnings for its fourth quarter.
&bull; Mesa Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLAB#NASDAQ">MLAB</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $54.89 million.
&bull; Air Products &amp; Chemicals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) is expected to report quarterly earnings at $3.00 per share on revenue of $3.20 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Bright Scholar Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEDU#NYSE">BEDU</a>) is projected to report earnings for its first quarter.
&bull; IRSA Inversiones y (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRS#NYSE">IRS</a>) is estimated to report earnings for its second quarter.
&bull; Kilroy Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRC#NYSE">KRC</a>) is projected to report earnings for its fourth quarter.
&bull; BellRing Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) is estimated to report quarterly earnings at $0.39 per share on revenue of $412.86 million.
&bull; Hillenbrand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) is expected to report quarterly earnings at $0.68 per share on revenue of $777.81 million.
&bull; NXP Semiconductors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) is estimated to report quarterly earnings at $3.63 per share on revenue of $3.40 billion.
&bull; Symbotic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) is likely to report quarterly loss at $0.06 per share on revenue of $368.89 million.
&bull; Golub Capital BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBDC#NASDAQ">GBDC</a>) is likely to report quarterly earnings at $0.48 per share on revenue of $160.51 million.
&bull; Kforce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KFRC#NASDAQ">KFRC</a>) is projected to report quarterly earnings at $0.79 per share on revenue of $363.36 million.
&bull; Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) is estimated to report quarterly earnings at $4.09 per share on revenue of $2.51 billion.
&bull; Itau Unibanco Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITUB#NYSE">ITUB</a>) is estimated to report quarterly earnings at $0.19 per share on revenue of $7.99 billion.
&bull; United States Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) is projected to report quarterly earnings at $0.37 per share on revenue of $299.98 million.
&bull; Palantir Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $602.55 million.
&bull; Skyline Champion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKY#NYSE">SKY</a>) is estimated to report quarterly earnings at $0.64 per share on revenue of $499.72 million.
&bull; AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) is likely to report quarterly earnings at $0.95 per share on revenue of $3.66 billion.
&bull; Amkor Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $1.68 billion.
&bull; Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) is likely to report quarterly earnings at $0.26 per share on revenue of $1.12 billion.
&bull; Simpson Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSD#NYSE">SSD</a>) is estimated to report quarterly earnings at $1.48 per share on revenue of $482.21 million.
&bull; Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) is projected to report quarterly earnings at $2.03 per share on revenue of $693.15 million.
&bull; Kimball Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KE#NASDAQ">KE</a>) is estimated to report quarterly earnings at $0.44 per share on revenue of $435.67 million.
&bull; Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) is likely to report quarterly earnings at $1.49 per share on revenue of $952.85 million.
&bull; ChampionX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHX#NASDAQ">CHX</a>) is likely to report quarterly earnings at $0.44 per share on revenue of $950.17 million.
&bull; Crown Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) is estimated to report quarterly earnings at $1.43 per share on revenue of $2.95 billion.
&bull; Flexsteel Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLXS#NASDAQ">FLXS</a>) is likely to report quarterly earnings at $0.56 per share on revenue of $102.12 million.
&bull; Gladstone Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLAD#NASDAQ">GLAD</a>) is projected to report quarterly earnings at $0.28 per share on revenue of $23.39 million.
&bull; Rambus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) is estimated to report quarterly earnings at $0.45 per share on revenue of $134.00 million.
&bull; Chegg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) is estimated to report quarterly earnings at $0.36 per share on revenue of $187.44 million.
&bull; Simon Property Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPG#NYSE">SPG</a>) is estimated to report earnings for its fourth quarter.
&bull; Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) is estimated to report quarterly earnings at $0.23 per share on revenue of $151.88 million.
&bull; Intevac (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVAC#NASDAQ">IVAC</a>) is estimated to report quarterly loss at $0.12 per share on revenue of $9.70 million.
&bull; FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) is estimated to report quarterly earnings at $1.08 per share on revenue of $1.25 billion.
&bull; J&amp;J Snack Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JJSF#NASDAQ">JJSF</a>) is expected to report quarterly earnings at $0.78 per share on revenue of $362.88 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

AMKR

BEDU

BOWL

BRBR

CHGG

COHR

FLXS

GBDC

GLAD

IDXX

ITUB

IVAC

JJSF

KFRC

MLAB

MUFG

NSSC

NXPI

PLTR

RMBS

SPHR

VRNS

VRTX

Earnings Scheduled For February 5, 2024

Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) is set to give its latest quarterly earnings report on Monday, 2024-02-05. Here's what investors need to know before the announcement.
Analysts estimate that Cabot will report an earnings per share (EPS) of $1.49. 
Cabot bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.17, which was followed by a 8.31% increase in the share price the next day.
Here's a look at Cabot's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.48</td>
<td>1.56</td>
<td>1.31</td>
<td>0.97</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.65</td>
<td>1.42</td>
<td>1.33</td>
<td>0.98</td>
</tr>
<tr>
<td>Price Change %</td>
<td>8.31%</td>
<td>1.77%</td>
<td>-3.47%</td>
<td>1.86%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1706882572_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Cabot were trading at $73.18 as of January 31. Over the last 52-week period, shares are down 2.03%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CBT/earnings">To track all earnings releases for Cabot visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cabot's Earnings: A Preview

<h3>What Defines a Value Stock?</h3>
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. 
<h2>Benzinga Insights has compiled a list of value stocks in the basic materials sector that may be worth watching:</h2>
<ol>
<li>Clearwater Paper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) - P/E: 6.92</li>
<li>ArcelorMittal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MT#NYSE">MT</a>) - P/E: 5.32</li>
<li>Vale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VALE#NYSE">VALE</a>) - P/E: 6.69</li>
<li>Compañía de Minas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BVN#NYSE">BVN</a>) - P/E: 6.52</li>
<li>Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) - P/E: 9.66</li>
</ol>
Clearwater Paper's earnings per share for Q3 sits at $2.19, whereas in Q2, they were at 1.74. Most recently, ArcelorMittal reported earnings per share at $1.1, whereas in Q2 earnings per share sat at $2.2. Most recently, the company reported a dividend yield of 1.28%, which has increased by 0.51% from last quarter's yield of 0.77%.
Most recently, Vale reported earnings per share at $0.66, whereas in Q2 earnings per share sat at $0.2. Compañía de Minas has reported Q3 earnings per share at $-0.11, which has decreased by 266.67% compared to Q2, which was -0.03. The company's most recent dividend yield sits at 1.41%, which has increased by 0.69% from 0.72% last quarter. 
Cabot has reported Q4 earnings per share at $1.65, which has increased by 16.2% compared to Q3, which was 1.42. Most recently, the company reported a dividend yield of 2.1%, which has decreased by 0.11% from last quarter's yield of 2.21%.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

VALE

5 Value Stocks In The Basic Materials Sector

CBT, ATLX and GURE are among materials movers

In a report released yesterday, Jeffrey Zekauskas from J.P. Morgan maintained a Hold rating on Cabot (CBT – Research Report), with a price target o...

J.P. Morgan Keeps Their Hold Rating on Cabot (CBT)

Dividend Champion, Contender, And Challenger Highlights: Week Of May 12

Cabot: Reinforcement Materials Strength To Continue To Drive Earnings Forward

Dividend Champion, Contender, And Challenger Highlights: Week Of May 26

13 Upcoming Dividend Increases

Dividend Champion, Contender, And Challenger Highlights: Week Of June 9

Chemical products play vital roles in everyday life, serving as raw materials for countless products and processes. Given its resilient demand, investors might consider chemical stocks H.B. Fuller Company (FUL), Cabot Corp (CBT), and NewMarket Corp (NEU), which have strong growth prospects. Read more… The chemical business is growing due to the rising demand for chemicals used in consumer goods, infrastructure development, and industrial activities. Thus, I think it would be wise to buy chemical stocks, H.B. Fuller Company (<a href="https://stocknews.com/stock/FUL/">FUL</a>), Cabot Corporation (<a href="https://stocknews.com/stock/CBT/">CBT</a>), and  NewMarket Corporation (<a href="https://stocknews.com/stock/NEU/">NEU</a>), which have strong growth prospects.
The chemicals market is expected to see strong growth in the next few years. It will grow to $7.79 trillion in 2028 at a <a href="https://www.researchandmarkets.com/reports/5781388/chemicals-global-market-report">CAGR of 8.7%</a>. The anticipated growth in the chemicals market is expected to be propelled by the increasing demand for inorganic chemicals in the fertilizer industry. Also, this sector is integral to various industries, such as manufacturing, construction, agriculture, healthcare, and consumer goods.
Moreover, the chemical industry is broadly adopting AI to enhance processes and discoveries. AI aids chemists from research to production, using techniques like machine learning and deep learning to speed up drug discovery and materials development. Hence, AI in the chemical market is expected to reach $20.55 billion by 2033, <a href="https://www.precedenceresearch.com/artificial-intelligence-in-the-chemical-market">growing at a CAGR of 31%</a>.
Considering these encouraging trends, let's take a look at the fundamentals of the three best <a href="https://stocknews.com/category/chemicals/">Chemicals</a> industry stocks, beginning with the third choice.
Stock #3: H.B. Fuller Company (<a href="https://stocknews.com/stock/FUL/">FUL</a>)
FUL formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
In terms of the trailing-12-month gross profit margin, FUL's 29.87% is 5.1% higher than the 28.41% industry average. Its 11.64% trailing-12-month EBIT margin is 12.2% higher than the 10.38% industry average. Likewise, the stock's 3.29% trailing-12-month <a href="https://www.investopedia.com/terms/r/return_on_total_assets.asp">ROTA</a> is 21.4% higher than the 2.71% industry average.
During the first quarter, which ended March 2, 2024, FUL's net revenue increased marginally year-over-year to $810.42 million. The company's gross profit and net income grew 11.4% and 41.6% year-over-year to $239.24 million and $30.99 million, respectively. Also, its income per common share attributable to FUL rose 41% from the prior-year quarter to $0.55.
Analysts expect FUL's revenue for the second quarter (ending May 2024) to increase 1.7% year-over-year to $913.32 million. Its EPS is expected to increase 10.5% year-over-year to $1.03.
FUL's revenue grew at a CAGR of 7% over the past three years. In addition, its total assets grew at a CAGR of 4.4% over the same time frame.
Over the past nine months, FUL's stock has gained 18.1% to close the last trading session at $78.67.
FUL's robust fundamentals are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
The stock has a B grade for Stability, Growth, and Sentiment. FUL is ranked #15 among 81 stocks in the B-rated <a href="https://stocknews.com/category/chemicals/">Chemicals</a> industry.
<a href="https://stocknews.com/stock/FUL/">Click here</a> to access additional FUL ratings (Value, Momentum, and Quality).
Stock #2: Cabot Corporation (<a href="https://stocknews.com/stock/CBT/">CBT</a>)
CBT is a specialty chemicals and performance materials company with two segments: Reinforcement Materials and Performance Chemicals.
On May 13, 2024, CBT launched new REPLASBLAK universal circular black masterbatches with certified sustainable material. The new REPLASBLAK universal circular black masterbatches, developed with EVOLVE&#xAE; Sustainable Solutions, should allow Cabot to consistently provide the high-performance, quality, and reliability demanded by the plastics industry for certified circular solutions on a large scale.
In terms of the trailing-12-month EBIT margin, CBT's 15.24% is 46.9% higher than the 10.38% industry average. Its 19.10% trailing-12-month EBITDA margin is 16.2% higher than the 16.44% industry average. Likewise, the stock's 12.51% trailing-12-month ROTA is 361.9% higher than the 2.71% industry average.
CBT's net sales and other operating revenues for the second quarter ended March 31, 2024, were $1.02 billion. The company's net income grew 18.3% year-over-year to $97 million. Its adjusted earnings per share increased 33.8% year-over-year to $1.78.
Analysts expect CBT's revenue for the third quarter ending June 30, 2024, to increase 3.7% year-over-year to $1 billion. Its EPS for the same quarter is expected to grow 20.2% year-over-year to $1.71. Moreover, the company has surpassed EPS estimates in three of the trailing four quarters.
CBT's revenue grew at a CAGR of 12.2% over the past three years. In addition, its total assets grew at a CAGR of 5.7% over the same time frame.
Shares of CBT have surged 43.5% over the past nine months to close the last trading session at $96.16.
CBT's bright prospects are reflected in its POWR Ratings. The stock has an overall rating of B, equating to a Buy in our proprietary rating system.
CBT has a B grade for Growth, Quality, and Stability. It is ranked #9 in the same industry.
In addition to the POWR Ratings we've stated above, we also have CBT ratings for Momentum, Sentiment, and Value. Get all CBT ratings <a href="https://stocknews.com/stock/CBT/">here</a>.
Stock #1: NewMarket Corporation (<a href="https://stocknews.com/stock/NEU/">NEU</a>)
NEU primarily engages in the manufacture and sale of petroleum additives. The company offers lubricant additives for use in various vehicle and industrial applications, including engine oils, transmission fluids, off-road powertrains, and hydraulic systems.
On April 25, 2924, NEU declared a quarterly dividend of $2.50 per share on the common stock of the Corporation, payable July 1, 2024.
The company pays $10 annually, which translates to a yield of 1.91% on the prevailing price level. Its four-year average dividend yield is 2.18%. Over the past three and five years, the company has raised its dividend payouts at a CAGR of 7.7% and 6.3%, respectively.
In terms of the trailing-12-month EBIT margin, NEU's 19.95% is 92.2% higher than the 10.38% industry average. Its 23.05% trailing-12-month EBITDA margin is 40.3% higher than the 16.44% industry average. Likewise, the stock's 12.64% trailing-12-month ROTA is 366.5% higher than the 2.71% industry average.
During the first quarter, which ended March 31, 2024, NEU reported net sales of $696.74 million. Its gross profit increased 9.3% from the previous-year quarter to $216.37 million. The company's net income and EPS were $107.73 million and $11.23, up 10.4% and 11.3% year-over-year, respectively.
NEU's revenue grew at a CAGR of 10.1% over the past three years. In addition, its total assets grew at a CAGR of 9.6% over the same time frame.
NEU's stock has gained 30.7% over the past year to close the last trading session at $522.82.
NEU's POWR Ratings reflect its promising outlook. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. 
The stock has a B grade for Growth, Stability, and Quality. Within the same industry, NEU is ranked #8.
<a href="https://stocknews.com/stock/NEU/">Click here</a> to access additional ratings of NEU for Value, Momentum, and Sentiment.
What To Do Next?
Discover 10 widely held stocks that our proprietary model shows have tremendous downside potential. Please make sure none of these "death trap" stocks are lurking in your portfolio:
<a href="https://report.stocknews.com/free-report/10-stocks-to-sell/?formplacement=artbotad_10sell">10 Stocks to SELL NOW! &gt;</a>

<hr />
CBT shares were trading at $94.46 per share on Tuesday afternoon, down $1.70 (-1.77%). Year-to-date, CBT has gained 14.16%, versus a 14.79% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Nidhi Agarwal</h2> <img src='https:/wp-content/uploads/2023/03/Nidhi-Agarwal_Headshot-3.jpg' style="float:left; padding:5px;width:125px;">Nidhi is passionate about the capital market and wealth management, which led her to pursue a career as an investment analyst. She holds a bachelor's degree in finance and marketing and is pursuing the CFA program.

Her fundamental approach to analyzing stocks helps investors identify the best investment opportunities.<a href="https://stocknews.com/authors/?author=nidhi-agarwal">More...</a>The post <a href=https://stocknews.com/news/cbt-neu-ful-top-3-chemicals-stocks-with-strong-growth-prospects/>Top 3 Chemicals Stocks With Strong Growth Prospects</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Top 3 Chemicals Stocks With Strong Growth Prospects

Cabot declares $0.43 dividend

The latest announcement is out from Cabot (CBT). Cabot Corporation has enhanced its Board of Directors by electing Thierry Vanlancker, who will als...

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Cabot

Cabot (CBT) Forecast

Cabot (NYSE:CBT) Stock, Quote.Headers.trade-ideas